NS5A inhibitors (Medivir)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameNS5A inhibitors (Medivir)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNonstructural protein 5A inhibitors

TargetsNonstructural protein 5A

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMedivir AB

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMedivir AB

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A